Literature DB >> 24736286

Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions.

Chad R Borges1, Douglas S Rehder2, Sally Jensen3, Matthew R Schaab2, Nisha D Sherma2, Hussein Yassine4, Boriana Nikolova5, Christian Breburda6.   

Abstract

S-cysteinylated albumin and methionine-oxidized apolipoprotein A-I (apoA-I) have been posed as candidate markers of diseases associated with oxidative stress. Here, a dilute-and-shoot form of LC-electrospray ionization-MS requiring half a microliter of blood plasma was employed to simultaneously quantify the relative abundance of these oxidized proteoforms in samples stored at -80 °C, -20 °C, and room temperature and exposed to multiple freeze-thaw cycles and other adverse conditions in order to assess the possibility that protein oxidation may occur as a result of poor sample storage or handling. Samples from a healthy donor and a participant with poorly controlled type 2 diabetes started at the same low level of protein oxidation and behaved similarly; significant increases in albumin oxidation via S-cysteinylation were found to occur within hours at room temperature and days at -20 °C. Methionine oxidation of apoA-I took place on a longer time scale, setting in after albumin oxidation reached a plateau. Freeze-thaw cycles had a minimal effect on protein oxidation. In matched collections, protein oxidation in serum was the same as that in plasma. Albumin and apoA-I oxidation were not affected by sample headspace or the degree to which vials were sealed. ApoA-I, however, was unexpectedly found to oxidize faster in samples with lower surface-area-to-volume ratios. An initial survey of samples from patients with inflammatory conditions normally associated with elevated oxidative stress-including acute myocardial infarction and prostate cancer-demonstrated a lack of detectable apoA-I oxidation. Albumin S-cysteinylation in these samples was consistent with known but relatively brief exposures to temperatures above -30 °C (the freezing point of blood plasma). Given their properties and ease of analysis, these oxidized proteoforms, once fully validated, may represent the first markers of blood plasma specimen integrity based on direct measurement of oxidative molecular damage that can occur under suboptimal storage conditions.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24736286      PMCID: PMC4083123          DOI: 10.1074/mcp.M114.038455

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  40 in total

Review 1.  Human biospecimen research: experimental protocol and quality control tools.

Authors:  Fotini Betsou; Rebecca Barnes; Thomas Burke; Domenico Coppola; Yvonne Desouza; James Eliason; Barbara Glazer; David Horsfall; Cynthia Kleeberger; Sylvain Lehmann; Anil Prasad; Amy Skubitz; Stella Somiari; Elaine Gunter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

Review 2.  Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group.

Authors:  Fotini Betsou; Elaine Gunter; Judith Clements; Yvonne DeSouza; Katrina A B Goddard; Fiorella Guadagni; Wusheng Yan; Amy Skubitz; Stella Somiari; Trina Yeadon; Rodrigo Chuaqui
Journal:  J Mol Diagn       Date:  2012-11-27       Impact factor: 5.568

3.  Improving international research with clinical specimens: 5 achievable objectives.

Authors:  Joshua LaBaer
Journal:  J Proteome Res       Date:  2012-10-30       Impact factor: 4.466

Review 4.  Before you analyze a human specimen, think quality, variability, and bias.

Authors:  Mark David Lim; Anthony Dickherber; Carolyn C Compton
Journal:  Anal Chem       Date:  2010-11-29       Impact factor: 6.986

5.  Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity.

Authors:  Chad R Borges; Paul E Oran; Sai Buddi; Jason W Jarvis; Matthew R Schaab; Douglas S Rehder; Stephen P Rogers; Thomas Taylor; Randall W Nelson
Journal:  Clin Chem       Date:  2011-03-14       Impact factor: 8.327

6.  Cysteine sulfenic acid as an intermediate in disulfide bond formation and nonenzymatic protein folding.

Authors:  Douglas S Rehder; Chad R Borges
Journal:  Biochemistry       Date:  2010-09-07       Impact factor: 3.162

7.  Postprandial cysteine/cystine redox potential in human plasma varies with meal content of sulfur amino acids.

Authors:  Youngja Park; Thomas R Ziegler; Nana Gletsu-Miller; Yongliang Liang; Tianwei Yu; Carolyn Jonas Accardi; Dean P Jones
Journal:  J Nutr       Date:  2010-02-17       Impact factor: 4.798

Review 8.  Sulfenic acid--a key intermediate in albumin thiol oxidation.

Authors:  Lucía Turell; Horacio Botti; Sebastián Carballal; Rafael Radi; Beatriz Alvarez
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-28       Impact factor: 3.205

9.  2009 Biospecimen research network symposium: advancing cancer research through biospecimen science.

Authors:  Helen M Moore; Carolyn C Compton; Mark D Lim; Jimmie Vaught; Katerina N Christiansen; Joe Alper
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

Review 10.  Oxidation of the albumin thiol to sulfenic acid and its implications in the intravascular compartment.

Authors:  L Turell; S Carballal; H Botti; R Radi; B Alvarez
Journal:  Braz J Med Biol Res       Date:  2009-04       Impact factor: 2.590

View more
  9 in total

1.  Ex vivo instability of glycated albumin: A role for autoxidative glycation.

Authors:  Joshua W Jeffs; Shadi Ferdosi; Hussein N Yassine; Chad R Borges
Journal:  Arch Biochem Biophys       Date:  2017-07-13       Impact factor: 4.013

2.  Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.

Authors:  Shadi Ferdosi; Douglas S Rehder; Paul Maranian; Erik P Castle; Thai H Ho; Harvey I Pass; Daniel W Cramer; Karen S Anderson; Lei Fu; David E C Cole; Tao Le; Xifeng Wu; Chad R Borges
Journal:  J Proteome Res       Date:  2017-11-21       Impact factor: 4.466

3.  The Application of Multiple Reaction Monitoring to Assess Apo A-I Methionine Oxidations in Diabetes and Cardiovascular Disease.

Authors:  Hussein N Yassine; Angela M Jackson; Peter D Reaven; Dobrin Nedelkov; Randall W Nelson; Serrine S Lau; Christoph H Borchers
Journal:  Transl Proteom       Date:  2014-12-01

Review 4.  AIBP: A Novel Molecule at the Interface of Cholesterol Transport, Angiogenesis, and Atherosclerosis.

Authors:  Laurence Zhu; Longhou Fang
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Jul-Sep

5.  Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.

Authors:  Olgica Trenchevska; Nisha D Sherma; Paul E Oran; Peter D Reaven; Randall W Nelson; Dobrin Nedelkov
Journal:  J Proteomics       Date:  2014-12-27       Impact factor: 4.044

6.  A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.

Authors:  Thai H Ho; Rafael Nunez Nateras; Huihuang Yan; Jin G Park; Sally Jensen; Chad Borges; Jeong Heon Lee; Mia D Champion; Raoul Tibes; Alan H Bryce; Estrella M Carballido; Mark A Todd; Richard W Joseph; William W Wong; Alexander S Parker; Melissa L Stanton; Erik P Castle
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

7.  Phenotype-Driven Plasma Biobanking Strategies and Methods.

Authors:  Erica A Bowton; Sarah P Collier; Xiaoming Wang; Cara B Sutcliffe; Sara L Van Driest; Lindsay J Couch; Miguel Herrera; Rebecca N Jerome; Robbert J C Slebos; William E Alborn; Daniel C Liebler; Candace D McNaughton; Ray L Mernaugh; Quinn S Wells; Nancy J Brown; Dan M Roden; Jill M Pulley
Journal:  J Pers Med       Date:  2015-05-14

8.  Delta-S-Cys-Albumin: A Lab Test that Quantifies Cumulative Exposure of Archived Human Blood Plasma and Serum Samples to Thawed Conditions.

Authors:  Joshua W Jeffs; Nilojan Jehanathan; Stephanie M F Thibert; Shadi Ferdosi; Linda Pham; Zachary T Wilson; Christian Breburda; Chad R Borges
Journal:  Mol Cell Proteomics       Date:  2019-07-19       Impact factor: 5.911

9.  Aging-associated oxidized albumin promotes cellular senescence and endothelial damage.

Authors:  Carlos Luna; Matilde Alique; Estefanía Navalmoral; Maria-Victoria Noci; Lourdes Bohorquez-Magro; Julia Carracedo; Rafael Ramírez
Journal:  Clin Interv Aging       Date:  2016-02-29       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.